Perceptive Advisors
Venture capital
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
12Deep-tech portfolio4 active
8Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Relay Therapeutics
71Co-investorsShare a portfolio company
Portfolio · 12 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Prelude Therapeutics | Biotech | Active | Aug 28, 2020 | $97.0M |
| Nurix Therapeutics | Biotech | Active | Mar 26, 2020 | $142.5M |
| Lyell Immunopharma | Biotech | Active | Mar 20, 2020 | $493.0M |
| Disc Medicine | Biotech | Active | — | — |
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
| Entrada Therapeutics | Biotech | Public | Apr 13, 2021 | $150.9M |
| Imago BioSciences | Biotech | Acquired | Nov 20, 2020 | $105.8M |
| Vor Biopharma | Biotech | Public | Jul 10, 2020 | $110.1M |
| Passage Bio | Biotech | Public | Sep 6, 2019 | $110.0M |
| Synthego | Biotech | Acquired | Oct 23, 2018 | $155.7M |
| PMV Pharmaceuticals | Biotech | Public | Mar 2, 2017 | $73.7M |
| Day One Biopharmaceuticals | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#40
Portfolio exits#20
Raises, 12 months#88
Co-investors#11
Co-investors
- Third Rock VenturesVenture capital8 shared
- Atlas VentureVenture capital4 shared
- Boxer CapitalVenture capital4 shared
- Frazier Healthcare PartnersVenture capital4 shared
- Perceptive Life SciencesVenture capital4 shared
- Ascent Biomedical VenturesVenture capital3 shared
- Biotechnology Value FundVenture capital3 shared
- Brookside CapitalVenture capital3 shared
- Deerfield Capital ManagementVenture capital3 shared
- EcoR1 CapitalVenture capital3 shared
Sectors
- Biotech12
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.